|
Post by yossarian on Jun 1, 2015 10:11:41 GMT -5
Yes, but one would think a drug chain would send its pharmacies information about a new drug. Not sure Rite-Aid did it or not, though the pharmacist said he had heard of AFREZZA.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 1, 2015 11:01:50 GMT -5
The guy was probably asleep when the email came out on it.
|
|
|
Post by compound26 on Jul 2, 2015 14:59:34 GMT -5
It took me 6 weeks to see my endocrinologist for the initial 45 minute first appointment allotment slot. Less than one week to have IOS Spirometry test scheduled and one more week to see endocrinologist to evaluate test results. Two sample kits of Afrezza obtained that carry me another 20 days. From what I'm hearing, this is a typical timeline, if not slower than mine since my schedule fit the endocrinologist's or visa versa. I will not have my first script written until I see him again with my logbook on June 1st. The whole process from the initial endo phone call to Afrezza written script takes roughly 3-4 months. Now you can see why it's taking so long to build up script numbers (Nrx) and refills (Rrx)!! It hasn't even been 4 months since official launch date.
BTW, I am a T2 Afrezza user like my friend Spiro. It appears Brian's experience is in line with what was described in the following article. This also supports Matt's remark that the current scripts numbers is about 8 weeks behind the demand curve. Endocrine shortage -Shortfall in number of US endocrinologists www.bariatricnews.net/?q=news/111524/shortfall-number-us-endocrinologistsA growing shortage of endocrinologists could force patients to wait longer to see a doctor, according to a Endocrine Society workforce analysis published in the Journal of Clinical Endocrinology & Metabolism. The analysis found there is currently a shortage of about 1,500 adult and 100 paediatric full-time endocrinologists in the US. The demand for paediatric endocrinologists is expected to be met by 2016 as the workforce grows. The gap between supply and demand for adult endocrinologists, however, is expected to remain the same or grow worse as more people are diagnosed with endocrine conditions. This could lead to longer wait times for patients seeking appointments. The Society's survey found the average wait time for adults making a non-urgent appointment with an endocrinologist was 37 days in 2012. The average wait remained unchanged from 1999, despite a 52 percent increase in the number of board-certified endocrinologists serving adults.
|
|
|
Post by compound26 on Sept 18, 2015 17:02:48 GMT -5
It took me 6 weeks to see my endocrinologist for the initial 45 minute first appointment allotment slot. Less than one week to have IOS Spirometry test scheduled and one more week to see endocrinologist to evaluate test results. Two sample kits of Afrezza obtained that carry me another 20 days. From what I'm hearing, this is a typical timeline, if not slower than mine since my schedule fit the endocrinologist's or visa versa. I will not have my first script written until I see him again with my logbook on June 1st. The whole process from the initial endo phone call to Afrezza written script takes roughly 3-4 months. Now you can see why it's taking so long to build up script numbers (Nrx) and refills (Rrx)!! It hasn't even been 4 months since official launch date.
BTW, I am a T2 Afrezza user like my friend Spiro. The timeline described above appears to be consistent with what this tweet says: "#Afrezza My Wife recv'd 90 day supply of Afrezza today. It took 4 months to get Dr. appts,spirometer,samples,prescription,Ins prior auth." And here is what regenmedprovider says about this on a post of August 21. 2015 (see whythefutureisbrightformannkind.blogspot.com/?view=classic) regenmedprovider Additionally, as we approach another release of NRX and TRx numbers today. Last night I was able to bend the ears of the drug reps and a couple of pharmacists attending the presentation about NRx and TRx numbers. Samples do not show up in any of those numbers and most Afrezza patients are being given a 1-2 month supply of samples to get started and stabilized on dosage. Further, the TRx is only impacted when a refill is sought. Since, the typical roll out to each patient has been (1) couple of month of samples; (2) initial Rx which is the NRx, but is being written as a 90 days supply, then with 2-3 refills, the TRx numbers aren't affected until a patient has exhausted their 90 day supply. This is a 5 month lag from starting on Afrezza and a 3 month lag from the initial NRx. The Endo also confirmed that is how he is encouraging other providers to roll this out to patients and he is getting numerous calls from other Endo's and Primary Care Providers about Afrezza. Again, inhaled meds is a huge game changer but is quickly becoming of interest and adopted by prescribers. GLTA. Is that fair to say that the NRx/Refills we are seeing reflect prescriptions of patients who started the process of getting Afrezza prescribed in April/May/June (i.e., before DTC (Times) and to a great extent before ADA meeting) ? Please share your thoughts and observations.
|
|